[
    [
        {
            "time": "2021-01-01",
            "original_text": "2021年医药行业如何投资？高瓴A股医药公司持仓曝光",
            "features": {
                "keywords": [
                    "医药行业",
                    "高瓴",
                    "A股",
                    "投资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021年医药行业如何投资？高瓴A股医药公司持仓曝光",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-02-01",
            "original_text": "中泰证券---金域医学：业绩符合预期，新冠检测贡献较高增量【公司研究】",
            "features": {
                "keywords": [
                    "中泰证券",
                    "金域医学",
                    "新冠检测",
                    "业绩",
                    "增量"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券---金域医学：业绩符合预期，新冠检测贡献较高增量【公司研究】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-01",
            "original_text": "太平洋---金域医学：20Q4新冠仍有较大贡献，全年业绩高增长【公司研究】",
            "features": {
                "keywords": [
                    "太平洋",
                    "金域医学",
                    "新冠",
                    "20Q4",
                    "业绩",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "太平洋---金域医学：20Q4新冠仍有较大贡献，全年业绩高增长【公司研究】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-04-01",
            "original_text": "浙商证券---金域医学2020年业绩预告点评：全年业绩高增，看好新冠业务持续及高质量发展【公司研究】",
            "features": {
                "keywords": [
                    "浙商证券",
                    "金域医学",
                    "2020年",
                    "业绩",
                    "新冠业务",
                    "高质量发展"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券---金域医学2020年业绩预告点评：全年业绩高增，看好新冠业务持续及高质量发展【公司研究】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]